The role of the CCAAT-binding factor in Candida albicans
The role of the CCAAT-binding factor in Candida albicans
批准号:
7162149
负责人:
David Scott McNabb
金额:
$22.7万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2008-12-31
关键词:
AIDS therapyAcquired Immunodeficiency SyndromeAcuteAddressAdherenceAllelesAntifungal AgentsBiological AssayCCAAT-Binding FactorCandidaCandida albicansCandidiasisComplexConsensus SequenceCoupledDNA BindingDevelopmentDisruptionDrug Delivery SystemsElectrophoretic Mobility Shift AssayEukaryotaEukaryotic CellFailureFutureGene ExpressionGene Expression RegulationGene TargetingGenesGeneticGenomeGoalsHumanHuman DevelopmentImmunocompromised HostIncidenceInfectionLeadMagicModelingMolecularMusMutationMycosesNorthern BlottingNumbersOrganismPathogenesisPathway interactionsPatientsPeptidesPhenotypePredisposing FactorProteinsReporter GenesResearchRoleStandards of Weights and MeasuresSystemic infectionTechniquesTertiary Protein StructureTestingTherapeuticTherapeutic AgentsTherapeutic immunosuppressionTranscription CoactivatorTranscriptional RegulationVirulencechemotherapeutic agentchromatin immunoprecipitationdrug developmentfungusinnovationmutantnovelnovel strategiespathogenprogramspromoterprotein protein interactionsmall moleculetissue culturetranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Candic/a a/bicans is the most frequently encountered fungal pathogen in humans, and is
responsible for a variety of rnucocutaneous and systemic infections. There are a number of
predisposing factors that contribute to Canc/ida infections; however, the increasing number of
immunocomprornised patients (due primarily to imrnunosuppressive therapies and AIDS) has lead
to a sharp increase in the incidence of candidiasis. This fact, coupled with the limited arsenal of
therapeutic agents, dictates that current research efforts focus on elucidating pathways that
contribute to Candida virulence and on identifying novel targets for drug development. The long
term goal this research program is to investigate whether a unique structural feature of fungal
CCAAT-binding factors could serve as a target for antifungal compounds. The CCAAT-binding
factor is a heterooligomeric transcriptional activator that is highly conserved evolutionarily in all
eukaryotes; however, in fungi this transcription factor contains a novel subunit (termed Hap4p) that
is not found in other eukaryotes. It is the unique interaction of this fungal-specific subunit with other
components of the heteromeric complex that represents a potential target for drug development.
The failure of Hap4p to interact with the DNA-binding components of the complex results in the loss
of target gene expression. Thus, development of peptides or small molecules that inhibit this
fungal-specific protein-protein interaction could offer a viable approach to combating fungal
infections. The goal of the studies described in this proposal is to determine the regulatory function
of the CCAAT-binding factor in C. albicans, and to examine whether it is important in the regulation
of genes involved in virulence and pathogenesis, as the initial step toward exploring its potential as
a therapeutic drug target. The proposed studies will address the following specific aims: 1) to
generate mutants in the genes encoding the various subunits of the CCAAT-binding factor and
evaluate their phenotypes; 2) to determine whether the CCAAT-binding factor is important for C.
albicans virulence; and 3) to dissect the regulatory function of the CCAAT-binding factor.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
The role of the CCAAT-binding factor in Candida albicans
-
批准号:7000373
-
项目类别:
-
资助金额:$23.38万
-
财政年份:2003
-
负责人:David Scott McNabb
-
依托单位:
The role of the CCAAT-binding factor in Candida albicans
-
批准号:6680975
-
项目类别:
-
资助金额:$11.97万
-
财政年份:2003
-
负责人:David Scott McNabb
-
依托单位:
The role of the CCAAT-binding factor in Candida albicans
-
批准号:6764230
-
项目类别:
-
资助金额:$23.94万
-
财政年份:2003
-
负责人:David Scott McNabb
-
依托单位:
The role of the CCAAT-binding factor in Candida albicans
-
批准号:6834618
-
项目类别:
-
资助金额:$23.94万
-
财政年份:2003
-
负责人:David Scott McNabb
-
依托单位:
海外基金